Vanguard Group’s Inhibikase Therapeutics IKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29M | Buy |
3,224,370
+375,707
| +13% | +$733K | ﹤0.01% | 3130 |
|
|
2025
Q1 | $6.24M | Buy |
2,848,663
+10,018
| +0.4% | +$21.9K | ﹤0.01% | 3085 |
|
|
2024
Q4 | $9.23M | Buy |
2,838,645
+2,821,921
| +16,873% | +$9.17M | ﹤0.01% | 3001 |
|
|
2024
Q3 | $21.7K | Hold |
16,724
| – | – | ﹤0.01% | 4298 |
|
|
2024
Q2 | $20.2K | Hold |
16,724
| – | – | ﹤0.01% | 4359 |
|
|
2024
Q1 | $36.1K | Sell |
16,724
-65,321
| -80% | -$141K | ﹤0.01% | 4347 |
|
|
2023
Q4 | $104K | Sell |
82,045
-5,402
| -6% | -$6.86K | ﹤0.01% | 4294 |
|
|
2023
Q3 | $122K | Sell |
87,447
-863
| -1% | -$1.2K | ﹤0.01% | 4322 |
|
|
2023
Q2 | $319K | Sell |
88,310
-441,966
| -83% | -$1.6M | ﹤0.01% | 4225 |
|
|
2023
Q1 | $349K | Hold |
530,276
| – | – | ﹤0.01% | 4215 |
|
|
2022
Q4 | $265K | Buy |
530,276
+178
| +0% | +$89 | ﹤0.01% | 4248 |
|
|
2022
Q3 | $482K | Hold |
530,098
| – | – | ﹤0.01% | 4223 |
|
|
2022
Q2 | $394K | Hold |
530,098
| – | – | ﹤0.01% | 4344 |
|
|
2022
Q1 | $785K | Buy |
530,098
+51,394
| +11% | +$76.1K | ﹤0.01% | 4283 |
|
|
2021
Q4 | $704K | Hold |
478,704
| – | – | ﹤0.01% | 4360 |
|
|
2021
Q3 | $909K | Buy |
478,704
+8,089
| +2% | +$15.4K | ﹤0.01% | 4266 |
|
|
2021
Q2 | $1.32M | Buy |
+470,615
| New | +$1.32M | ﹤0.01% | 4094 |
|